Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal and systemic vascular resistance in progression of chronic kidney disease
2010-023979-25Phase 4Completed
- Sponsor
- Department of Nephrology
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of losartan, amlodipine and metoprolol in chronic kidney disease (CKD), Arterionephrosclerosis (ANS) and hypertension (HTN) (2 arms), sponsored by Department of Nephrology. Primary endpoint: Change in glomerular filtration rate. Started Dec 2010; status: completed.
02
Drugs
losartanamlodipinemetoprolol
03
Conditions
chronic kidney disease (CKD)Arterionephrosclerosis (ANS)hypertension (HTN)
Beyond the preview
Go deeper on 2010-023979-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023979-25.